Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Mirati Therapeutics (NQ: MRTX)
105.14 USD  +2.52 (+2.46%)
Streaming Delayed Price  /  Updated: 10:04 AM EST, Dec 9, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 133,093
Open 103.40
Bid (Size) 104.89 (1)
Ask (Size) 105.30 (1)
Prev. Close 102.62
Today's Range 103.40 - 105.51
52wk Range 34.39 - 111.99
Shares Outstanding 32,214,631
Dividend Yield N/A
Performance
YTD
+135.49%
+135.49%
1 Month
+0.35%
+0.35%
3 Month
+27.14%
+27.14%
6 Month
+4.38%
+4.38%
1 Year
+159.30%
+159.30%
Top News
More News
Mirati Therapeutics Presents Data From Ongoing Clinical Trials Of Sitravatinib In Combination With Nivolumab At The SITC 34th Annual Meeting
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced the presentation of initial data from its ongoing Phase 2 clinical trial of sitravatinib in... Read More
from PR Newswire
Mirati Therapeutics Reports Third Quarter 2019 Financial Results
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter ended September 30, 2019. Read More
from PR Newswire
More News
Read More
Mirati Therapeutics Presents First Clinical Data Of Phase 1/2 Trial Of MRTX849 At The 2019 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics
from PR Newswire
AstraZeneca CEO: Closing In On A Cancer Cure
category Biotech , Benzinga , MYOV , and 11 more.
from Benzinga
Noteworthy Friday Option Activity: MRTX, DHR, AXE
category Stocks
from Market News Video
Noteworthy Tuesday Option Activity: MRTX, R, GPRE
category Stocks
from Market News Video
3 Cancer Treatment Stocks to Buy Right Now
category GH , MRTX , PSNL , and 3 more.
from Motley Fool
Mid-Afternoon Market Update: Athenex Shares Spike; Grubhub Nosedives On Earnings Miss
category Benzinga , TXRH , Intraday Update , and 16 more.
from Benzinga
Better Buy: Mirati Therapeutics vs. Amgen
category MRTX , BMY , Market News , and 1 more.
from Motley Fool
Mid-Morning Market Update: Markets Mixed; General Motors Profit Beats Views
category KNSA , GRUB , Mid/Morning Market Update , and 16 more.
from Benzinga
Can This Tiny Biotech Take Down Amgen?
category MRTX , AMGN , Market News
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.